AbbVie Inc. Pre-tax Income 2011-2026 | ABBV
Beta
What is AbbVie Inc.'s current pre-tax income?
AbbVie Inc. (ABBV) annual pre-tax income for 2025 was $6.60B, a 77.53% increase from 2024. AbbVie Inc. pre-tax income for the quarter ending March 31, 2026 was $1.04B.
What was AbbVie Inc.'s pre-tax income in 2024?
AbbVie Inc. annual pre-tax income for 2024 was $3.72B, a 40.54% decline from 2023.
What was AbbVie Inc.'s pre-tax income in 2023?
AbbVie Inc. annual pre-tax income for 2023 was $6.25B, a 53.62% decline from 2022.
What is AbbVie Inc.'s 5-year pre-tax income CAGR?
AbbVie Inc. pre-tax income grew at a compound annual growth rate (CAGR) of 14.19% from FY2020 to FY2025, going from $3.40B to $6.60B over 5 years.
Pre-tax Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+14.2%
FY2020
$3.40B
→
FY2025
$6.60B
111213141516171819202122232425
5 years selected
Pre-tax Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $6.60B | +77.5% | 10-K |
| FY2024 | $3.72B | -40.5% | 10-K |
| FY2023 | $6.25B | -53.6% | 10-K |
| FY2022 | $13.48B | +3.8% | 10-K |
| FY2021 | $12.99B | +282.3% | 10-K |
| FY2020 | $3.40B | -59.7% | 10-K |
| FY2019 | $8.43B | +62.1% | 10-K |
| FY2018 | $5.20B | -32.7% | 10-K |
| FY2017 | $7.73B | -2.0% | 10-K |
| FY2016 | $7.88B | +18.6% | 10-K |
| FY2015 | $6.64B | +180.5% | 10-K |
| FY2014 | $2.37B | -55.6% | 10-K |
| FY2013 | $5.33B | -6.9% | 10-K |
| FY2012 | $5.72B | +56.1% | 10-K |
| FY2011 | $3.67B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →